Clinical Trial Update: Dapagliflozin in Mangement of Pulmonary Hypertension Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating dapagliflozin for management of pulmonary hypertension; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Assiut University | Conditions: Pulmonary Hypertension | Phase 1 | Status: NOT_YET_RECRUITING